Session 1 - Risk stratification and prognosis -- Session 2 - Screening and surveillance: invasive and noninvasive methods -- Session 3 - Changing scenarios I: Impact of etiological therapy for cirrhosis and of anti-fibrotic therapy on portal hypertension -- Session 4 - The gut microbiome and cirrhosis -- Session 5 - Changing scenarios II: What to do after successful cure of the etiologic factor? -- Session 6 - Management of the acute bleeding episode -- Session 7 - Controversies and challenges in Pediatrics -- Session 8 - Prevention of further decompensation (ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, hepatic encephalopathy) -- Session 9 Vascular diseases of the liver in cirrhotic and non-cirrhotic portal hypertension: coagulation, anti-coagulation, anti-platelet drugs.

This book will be an excellent tool for practitioners seeking an update on the latest developments in the diagnosis and management of cirrhosis and portal hypertension. Among the topics addressed are risk stratification, prognosis, screening and surveillance, impact of etiological and antifibrotic therapy, the gut microbiome and cirrhosis, prevention of decompensation/further decompensation, management of the acute bleeding episode, controversies in pediatrics, and vascular diseases of the liver in cirrhotic and noncirrhotic portal hypertension. The book is a compilation of lectures and important consensus statements from the Sixth Baveno International Consensus Workshop on Portal Hypertension, the most recent of a series of workshops held every 5 years for hepatologists with an interest in the field. Portal Hypertension VI will serve as a reference book for clinical and research fellows in Gastroenterology and Hepatology and should inspire new research projects in the areas identified as promising by the experts of the Baveno VI Faculty.